Skip to main content
Clinical Trials/NCT05406791
NCT05406791CompletedNot Applicable

Technology Enabled Services to Enhance Depression Care

Northwestern University1 site in 1 country130 target enrollmentStarted: June 10, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
130
Locations
1
Primary Endpoint
Patient Health Questionaire-9 (PHQ-9)

Study Overview

Brief Summary

This study will compare two digital mental health interventions (DMHIs). One DMHI will use an app called Vira (which is a product developed and managed by Ksana Health), along with low intensity coaching provided via phone and both SMS text and in-app messaging. The other DMHI will provide a broad range of information on how to manage symptoms of depression, anxiety, and stress. The DMHI will be evaluated with patients receiving care from Rush University Medical Center's primary care and family medicine clinics, which serve racially, ethnically, and economically diverse communities; evaluations may also be extended beyond Rush patients.

Detailed Description

Depression and anxiety are common and impose a tremendous societal burden in terms of cost, morbidity, quality of life, and mortality. Yet, few people are able to obtain adequate or appropriate treatment.

This trial will compare the ability of two digital mental health interventions (DMHIs) to reduce depression and anxiety. One DMHI, called Mood Education App, provides information on depression and a broad range of strategies that are effective in improving symptoms. The other app, called VIRA, uses smartphone sensors to identify a few behavioral markers, including mobility patterns, physical activity, and sleep. The results of these sensed behavioral markers are used to give the participant behavior change recommendations through the Vira app that are expected to result in symptom improvement. The DMHI will include low intensity coaching, which includes one or more brief phone calls and communication via SMS text and in-app messaging. Both treatments are 8-weeks long.

The trial will be conducted within Rush University Medical Center's primary care and family medicine clinics, although recruitment be expanded beyond these clinics.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
13 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • US Citizen/ Resident
  • 13 years or older
  • English Speaking
  • Owns an Android or iPhone smartphone with an up-to-date operating system
  • Has used a smartphone in the last 7 days
  • PHQ-8 greater than or equal to 10 and/or GAD-7 greater than or equal to 10

Exclusion Criteria

  • Children under the age of 13
  • Severe suicidality (as defined by presence of a plan + intent to act on that plan)

Arms & Interventions

Sensor-enabled digital mental health intervention (DMHI)

Experimental

Patients randomized to sensor-enabled DMHI condition will use Ksana Health's "Vira" mobile therapy platform with support from a study coach

Intervention: VIRA App (Other)

Experimental: Control Treatment (CT)

Experimental

Participants randomized to the CT condition will use a Mood Education App designed by researchers at the University of Virginia to deliver psychoeducational content to help people self-manage symptoms of depression, anxiety, and stress.

Intervention: Mood Education App (Other)

Outcomes

Primary Outcomes

Patient Health Questionaire-9 (PHQ-9)

Time Frame: 12 weeks

The PHQ-9 measures depression symptom severity on a scale of 0-27, with higher scores indicating greater symptom severity.

Generalized Anxiety Disorder-7 (GAD-7)

Time Frame: 12 weeks

The GAD-7 measures anxiety symptom severity on a scale of 0-21, with higher scores indicating greater symptoms severity

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

David Mohr

Principal Investigator

Northwestern University

Study Sites (1)

Loading locations...

Similar Trials